Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Archives of General Surgery(Electronic Edition) ›› 2026, Vol. 20 ›› Issue (01): 30-34. doi: 10.3877/cma.j.issn.1674-0793.2026.01.006

Special Issue:

• Original Article • Previous Articles     Next Articles

Impact of structured pathology reporting on the quality of surgical pathology reports for hepatocellular carcinoma: A retrospective study

Yihang Xu1, Liting Peng2, Jiayi Lin2, Qinghua Cao2, Yuefeng Wang2, Lili Chen2, Bing Liao2,()   

  1. 1 Department of Gastrointestinal Surgery, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
    2 Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
  • Received:2026-01-21 Online:2026-02-01 Published:2026-03-06
  • Contact: Bing Liao

Abstract:

Objective

Based on the implementation of structured surgical pathology reports (SSRs) for primary hepatocellular carcinoma (HCC), this study used traditional narrative pathology reports (TSRs) as a comparator to evaluate the values of SSRs in improving the quality and standardization of pathological information.

Methods

This retrospective study included 699 HCC pathology reports from April 2022 to April 2025 in the First Affiliated Hospital of Sun Yat-sen University, with expert pathologist review serving as the gold standard, and compared TSRs and SSRs in terms of key information completeness and concordance with the gold standard.

Results

Implementation of SSRs led to significant reduction in overall underreporting rates, decreasing from 37.4%-82.4% before implementation to 0-38.3%. In comparison, TSRs exhibited underreporting rates of 0–97.5% for gross examination, 0.8%-97.7% for microscopic examination, and 45.6%-84.7% for surrounding and other organ invasion, whereas SSRs maintained underreporting rates below 12.6%. SSRs also significantly improved the concordance rates for growth pattern (38.6% vs 63.2%), capsule (19.0% vs 67.8%), capsule invasion (24.5% vs 74.1%), liver fibrosis stage (45.5% vs 56.1%), and hepatitis activity grade (5.7% vs 70.3%) (P<0.05).

Conclusion

SSRs can significantly improve the quality of pathology reports and better meet clinical diagnostic and therapeutic needs, providing real-world evidence for their standardized application in complex clinical settings for HCC.

Key words: Structured pathology report, Carcinoma, hepatocellular, Underreporting, Retrospective analysis, Red world evidence

京ICP 备07035254号-20
Copyright © Chinese Archives of General Surgery(Electronic Edition), All Rights Reserved.
Tel: 020-87331056 E-mail: pwwxcma2007@126.com
Powered by Beijing Magtech Co. Ltd